Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

MonoGen closes US$12.4 million financing

Reading Time 1 minute read Subscribe



GMP Securities

On May 15, 2007, medical diagnostics company MonoGen, Inc. announced that it had closed a short form prospectus equity offering for aggregate proceeds of US$12.4 million, including proceeds received upon the exercise of the underwriters' over-allotment option. The syndicate of underwriters for this financing was led by GMP Securities L.P., and included Canaccord Capital Corporation and Paradigm Capital Inc. The underwriters were advised by Rubin Rapuch, Georges Dubé and Jeffrey Klam of Fasken Martineau.



    Receive email updates from our team